SCHEMBL22250048

SCHEMBL22250048

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5ccncc5)c4)nc(-c4ccc5c(c4)sc4cc6c7ccccc7c7ccccc7c6cc45)n3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
NFKB1 P19838 1/20 0.38
RAB9A P51151 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ROCK2 O75116 1/20 0.38
MAP4K4 O95819 1/20 0.38
PRKCG P05129 1/20 0.38
LYN P07948 1/20 0.38
PRKACA P17612 1/20 0.38
RPS6KB1 P23443 1/20 0.38
AKT1 P31749 1/20 0.38
FLT3 P36888 1/20 0.38
CSNK1D P48730 1/20 0.38
CLK2 P49760 1/20 0.38
IRAK1 P51617 1/20 0.38
PRKX P51817 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22249719 0.92 KMT2A (0.40) MAPTROCK2MAP4K4PRKCGLYN
SCHEMBL22249658 0.92 KMT2A (0.40) MAPTROCK2MAP4K4PRKCGLYN
SCHEMBL22240734 0.88 PIK3CA (0.41) MAPTSMN1; SMN2RAB9ALIMK1PIK3CA
SCHEMBL22352526 0.88 PIK3CA (0.41) MAPTSMN1; SMN2RAB9ALIMK1PIK3CA
SCHEMBL22240741 0.88 PIK3CA (0.41) MAPTSMN1; SMN2RAB9ALIMK1PIK3CA
SCHEMBL22240953 0.88 PIK3CA (0.41) MAPTSMN1; SMN2RAB9ALIMK1PIK3CA
SCHEMBL22352368 0.87 PIM3 (0.40) MAPTSMN1; SMN2RAB9AROCK1LIMK1
SCHEMBL22352370 0.87 PIM3 (0.40) MAPTSMN1; SMN2RAB9AROCK1LIMK1
SCHEMBL21755949 0.87 PIM3 (0.40) MAPTSMN1; SMN2RAB9AROCK1LIMK1
SCHEMBL22352438 0.87 ADORA2A (0.39) MAPTSMN1; SMN2RAB9AHSD17B10CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200235306-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200235306-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, PIEZO1, ODC1 MAPT 1445/4885SMN1; SMN2 1178/4885NPC1 737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.